| View |
|
DRP-11005
|
Ascorbic Acid + Zinc
|
Cefortan-Z
|
45mg/4.5mg per mL
|
Syrup ( Oral Drops)
|
Vitamin/Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
03 March 2022
|
03 April 2027
|
| View |
|
DRP-11006
|
Ascorbic Acid (Vitamin C) + Zinc
|
Cefortan-Z
|
97.5mg/9mg per 5mL
|
Syrup
|
Vitamin/Mineral
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
03 March 2022
|
03 April 2027
|
| View |
|
DRP-10953
|
Dorzolamide (As Hydrochloride) + Timolol (As Maleate)
|
Blitidor
|
20 mg/5 mg per mL (2.0%/0.5% w/v)
|
Sterile Ophthalmic
Solution (Eye Drops)
|
-
|
Alwin DMD Pharmaceuticals
|
India
|
-
|
22 December 2021
|
22 December 2026
|
| View |
|
DRP-854
|
Folic Acid
|
Foleq
|
5 mg
|
Tablet
|
Anti-anemic
|
Marnets Pharma Corporation
|
Philippines
|
Automatic Renewal
|
01 February 2022
|
13 January 2027
|
| View |
|
DR-XY47637
|
Clotrimazole
|
Candigo
|
500 mg
|
Vaginal Suppository
|
-
|
Kusum Healthcare Pvt. Ltd.
|
India
|
-
|
28 December 2021
|
28 December 2026
|
| View |
|
BR-1384
|
Cholera Vaccine (Inactivated, Oral)
|
Euvichol-Plus
|
Formulation Each dose (1.5 mL), contains
Vibrio cholerae 01 Inaba Cairo 48 classical biotype, Heat inactivated Vibrio cholerae 01 Inaba Phil 6973 El Tor biotype, Formalin inactivated Vibrio cholerae 01 Ogawa Cairo 50 classical biotype, Formalin inactivated Vibrio cholerae 01 Ogawa Cairo 50 classical biotype, Heat inactivated Vibrio cholerae 0139 4260B, Formalin inactivated
300 LEU* 600 LEU* 300 LEU* 300 LEU* 600 LEU*
*LEU: Lipopolysaccharide ELISA Units
|
Oral Suspension
|
-
|
Eubiologici Co., Ltd
|
Korea
|
-
|
31 December 2021
|
31 December 2026
|
| View |
|
DRP-10922
|
Etomidate
|
Etomidine
|
2 mg/mL
|
Emulsion for Injection (I.V.)
|
General Anesthetic
|
Troikaa Pharmaceuticals Limited
|
India
|
Monitored Release (Reconstruction)/
|
08 February 2024
|
17 December 2026
|
| View |
|
DRP-10912
|
Esomeprazole (as sodium)
|
Yesom
|
20mg
|
Lyophilized Powder for Injection (IV)
|
-
|
Aspiro Pharma Limited
|
India
|
Initial (Correction)
|
29 September 2023
|
15 December 2026
|
| View |
|
DRP-10911
|
Esomeprazole (as sodium)
|
Yesom
|
40mg
|
Lyophilized Powder for Injection (IV)
|
-
|
Aspiro Pharma Limited
|
India
|
-
|
29 December 2021
|
29 December 2026
|
| View |
|
DRP-10991
|
Exemestane
|
Exmasin
|
25 mg
|
Film-Coated Tablet
|
Antineoplastic Agent (Aromatase Inhibitor)
|
Sun Pharmaceutical Industries Ltd.
|
India
|
Initial (Reconstruction)
|
27 June 2024
|
29 December 2026
|
| View |
|
DR-XY47645
|
Multivitamins + Minerals + Amino Acids + Vitis
vinifera L. (Grape) Seed
|
None
|
Each tablet contains: Beta Carotene (Vitamin A) Retinyl Palmitate (Vitamin A) Cholecalciferol (Vitamin D3) Ascorbic Acid (Vitamin C) d-Alpha Tocopheryl Succinate (Vitamin E) Pantothenic Acid (as D-Calcium Pantothenate) Niacin (Vitamin B3)
Thiamine (Vitamin B1) Riboflavin (Vitamin B2) Pyridoxine HCI (Vitamin B6) Biotin (Vitamin B7) Folic Acid (Vitamin B9) Cobalamin (Vitamin B12) Calcium Phosphorus Magnesium
12,500 IU Potassium 12,500 IU Zinc
200 IU Iron
80mg Copper 15 IU Manganese 15mg Selenium 10mg Chromium
5mg Molybdenum Smg Methylsulfonylmethane (MSM) 5mg L-methionine
Img Citrus Bioflavonoid Complex 200mcg Alpha Lipoic Acid
7.5mcg Silica
135mg Choline 100mg Inositol
50mg Vitis vinifera L. (Grape) Seed (Leucoselect)
25mg 12.5mg
5mg
Img 500mcg 100mcg 100mcg 25mcg 125mg 50mg 50mg 50mg 40mg 25mg 25mg
15mg
|
Tablet
|
-
|
Nexgen Pharma Inc.
|
United States of America
|
Initial [OTC]
|
29 December 2021
|
29 December 2026
|
| View |
|
DRP-10946
|
Gentamicin (as Sulfate)
|
Optigent
|
3 mg/mL ( 0.3 % w/v )
|
Ophthalmic / Otic Solution (Drops)
|
-
|
Egyptian International Pharmaceutical Industries Co.
|
Egypt
|
-
|
21 December 2021
|
21 December 2026
|
| View |
|
DRP-9420
|
Omeprazole
|
Ranzole
|
40 mg
|
Delayed Release Tablet
|
Proton Pump Inhibitor
|
Jiangxi Xierkangtai Pharmaceutical Co., Ltd.
|
China
|
Renewal
|
02 August 2023
|
05 December 2028
|
| View |
|
DRP-10973
|
Solifenacin Succinate
|
Solitor 10
|
10mg
|
Film-Coated Tablet
|
-
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial (Correction)
|
19 January 2023
|
27 December 2026
|
| View |
|
DR-XY47620
|
Cefoxitin (as sodium)
|
Trefoxin
|
1g
|
Powder for Injection (I.M./I.V.)
|
-
|
Sance Laboratories Pvt.Ltd.
|
India
|
-
|
20 December 2021
|
20 December 2026
|
| View |
|
DRP-10540
|
Iron (as Ferrous fumarate) + Vitamin B-Complex
|
Hydrofer
|
Formulation: Iron (as Ferrous fumarate) Thiamine mononitrate (Vitamin B1) Pyridoxine hydrochloride (Vitamin B6) Cyanocobalamin (Vitamin B12)
50 mg (equivalent to 150 mg Ferrous fumarate) 50 mg 25 mg 25 mcg
|
Capsule
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
28 December 2021
|
28 December 2026
|
| View |
|
DRP-5960-04
|
Losartan Potassium
|
Losartfix
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Antagonist
|
Windlas Biotech Private Limited (Plant-1)
|
India
|
Automatic Renewal
|
01 March 2023
|
04 February 2028
|
| View |
|
DRP-10987
|
Furosemide
|
Aefur
|
10 mg/mL (20 mg/2mL)
|
Solution for Injection (I.M./I.V.)
|
Diuretic
|
Sui Guan Chem, Ind. Co., Ltd.
|
Taiwan
|
Initial (Reconstruction)
|
16 January 2024
|
28 January 2026
|
| View |
|
DR-XY47640
|
Sodium Bicarbonate + Sodium Citrate + Citric Acid +
Tartaric Acid
|
Citrix Soda
|
1.76 g/630 mg/720 mg/890 mg per sachet
|
Effervescent Granules
|
-
|
Bliss GVS Pharma Ltd.
|
India
|
-
|
29 December 2021
|
29 December 2026
|
| View |
|
DRP-11009
|
Tiotropium (as bromide)
|
Tropair
|
18 mcg (equivalent to 10 mcg delivered-dose)
|
Dry Powder for Inhalation in Capsule
|
Anticholinergic
|
Mepro Pharmaceuticals Private Limited
|
India
|
Initial (Correction)
|
29 May 2024
|
29 December 2026
|